25 XP   0   0   10

Procept Biorobotics Corp
Buy, Hold or Sell?

Let's analyse Procept Biorobotics Corp together

PenkeI guess you are interested in Procept Biorobotics Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Procept Biorobotics Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Procept Biorobotics Corp

I send you an email if I find something interesting about Procept Biorobotics Corp.

Quick analysis of Procept Biorobotics Corp (30 sec.)










What can you expect buying and holding a share of Procept Biorobotics Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$5.51
Expected worth in 1 year
$7.15
How sure are you?
12.5%

+ What do you gain per year?

Total Gains per Share
$1.64
Return On Investment
3.1%

For what price can you sell your share?

Current Price per Share
$52.48
Expected price per share
$50.42 - $54.50
How sure are you?
50%

1. Valuation of Procept Biorobotics Corp (5 min.)




Live pricePrice per Share (EOD)

$52.48

Intrinsic Value Per Share

$-31.82 - $-37.55

Total Value Per Share

$-26.31 - $-32.04

2. Growth of Procept Biorobotics Corp (5 min.)




Is Procept Biorobotics Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$280.7m$227.4m-$159k-0.1%

How much money is Procept Biorobotics Corp making?

Current yearPrevious yearGrowGrow %
Making money-$26.2m-$23.3m-$2.8m-11.0%
Net Profit Margin-80.8%-124.9%--

How much money comes from the company's main activities?

3. Financial Health of Procept Biorobotics Corp (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#85 / 334

Most Revenue
#128 / 334

Most Profit
#298 / 334

Most Efficient
#227 / 334

What can you expect buying and holding a share of Procept Biorobotics Corp? (5 min.)

Welcome investor! Procept Biorobotics Corp's management wants to use your money to grow the business. In return you get a share of Procept Biorobotics Corp.

What can you expect buying and holding a share of Procept Biorobotics Corp?

First you should know what it really means to hold a share of Procept Biorobotics Corp. And how you can make/lose money.

Speculation

The Price per Share of Procept Biorobotics Corp is $52.48. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Procept Biorobotics Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Procept Biorobotics Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $5.51. Based on the TTM, the Book Value Change Per Share is $0.41 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.34 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Procept Biorobotics Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.54-1.0%-0.52-1.0%-0.43-0.8%-0.37-0.7%-0.37-0.7%
Usd Book Value Change Per Share-0.37-0.7%0.410.8%-0.34-0.7%0.340.7%0.340.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.37-0.7%0.410.8%-0.34-0.7%0.340.7%0.340.7%
Usd Price Per Share41.91-34.62-37.67-22.02-22.02-
Price to Earnings Ratio-19.41--16.73--22.45--13.03--13.03-
Price-to-Total Gains Ratio-114.81--67.05--112.80--79.40--79.40-
Price to Book Ratio7.61-8.28-8.58-4.94-4.94-
Price-to-Total Gains Ratio-114.81--67.05--112.80--79.40--79.40-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share52.48
Number of shares19
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.410.34
Usd Total Gains Per Share0.410.34
Gains per Quarter (19 shares)7.806.54
Gains per Year (19 shares)31.2026.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10312102616
20625205242
30948307968
40125114010594
501561450131120
601871760157146
702182070183172
802502380209198
902812690236224
1003123000262250

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.016.00.00.0%0.016.00.00.0%0.016.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.09.01.016.7%2.010.04.012.5%2.010.04.012.5%2.010.04.012.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.016.00.0%0.00.016.00.0%0.00.016.00.0%
Total Gains per Share1.03.00.025.0%2.09.01.016.7%2.010.04.012.5%2.010.04.012.5%2.010.04.012.5%

Fundamentals of Procept Biorobotics Corp

About Procept Biorobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Fundamental data was last updated by Penke on 2024-04-22 00:03:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Procept Biorobotics Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Procept Biorobotics Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Procept Biorobotics Corp to the Medical Devices industry mean.
  • A Net Profit Margin of -63.1% means that $-0.63 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Procept Biorobotics Corp:

  • The MRQ is -63.1%. The company is making a huge loss. -2
  • The TTM is -80.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-63.1%TTM-80.8%+17.7%
TTM-80.8%YOY-124.9%+44.1%
TTM-80.8%5Y-294.7%+213.9%
5Y-294.7%10Y-294.7%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-63.1%-12.4%-50.7%
TTM-80.8%-20.4%-60.4%
YOY-124.9%-14.8%-110.1%
5Y-294.7%-21.3%-273.4%
10Y-294.7%-25.0%-269.7%
1.1.2. Return on Assets

Shows how efficient Procept Biorobotics Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Procept Biorobotics Corp to the Medical Devices industry mean.
  • -6.8% Return on Assets means that Procept Biorobotics Corp generated $-0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Procept Biorobotics Corp:

  • The MRQ is -6.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.8%TTM-7.9%+1.1%
TTM-7.9%YOY-7.4%-0.5%
TTM-7.9%5Y-6.3%-1.6%
5Y-6.3%10Y-6.3%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.8%-4.1%-2.7%
TTM-7.9%-4.7%-3.2%
YOY-7.4%-4.8%-2.6%
5Y-6.3%-4.0%-2.3%
10Y-6.3%-5.2%-1.1%
1.1.3. Return on Equity

Shows how efficient Procept Biorobotics Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Procept Biorobotics Corp to the Medical Devices industry mean.
  • -9.8% Return on Equity means Procept Biorobotics Corp generated $-0.10 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Procept Biorobotics Corp:

  • The MRQ is -9.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.8%TTM-12.6%+2.8%
TTM-12.6%YOY-10.6%-2.0%
TTM-12.6%5Y-7.8%-4.7%
5Y-7.8%10Y-7.8%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.8%-4.2%-5.6%
TTM-12.6%-5.8%-6.8%
YOY-10.6%-5.7%-4.9%
5Y-7.8%-6.3%-1.5%
10Y-7.8%-7.1%-0.7%

1.2. Operating Efficiency of Procept Biorobotics Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Procept Biorobotics Corp is operating .

  • Measures how much profit Procept Biorobotics Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Procept Biorobotics Corp to the Medical Devices industry mean.
  • An Operating Margin of -67.8% means the company generated $-0.68  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Procept Biorobotics Corp:

  • The MRQ is -67.8%. The company is operating very inefficient. -2
  • The TTM is -84.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-67.8%TTM-84.4%+16.5%
TTM-84.4%YOY-107.9%+23.5%
TTM-84.4%5Y-269.8%+185.4%
5Y-269.8%10Y-269.8%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-67.8%-24.3%-43.5%
TTM-84.4%-16.4%-68.0%
YOY-107.9%-13.7%-94.2%
5Y-269.8%-19.9%-249.9%
10Y-269.8%-24.5%-245.3%
1.2.2. Operating Ratio

Measures how efficient Procept Biorobotics Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.68 means that the operating costs are $1.68 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Procept Biorobotics Corp:

  • The MRQ is 1.678. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.836. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.678TTM1.836-0.158
TTM1.836YOY2.079-0.243
TTM1.8365Y3.696-1.860
5Y3.69610Y3.6960.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6781.442+0.236
TTM1.8361.439+0.397
YOY2.0791.431+0.648
5Y3.6961.436+2.260
10Y3.6961.374+2.322

1.3. Liquidity of Procept Biorobotics Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Procept Biorobotics Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 7.63 means the company has $7.63 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Procept Biorobotics Corp:

  • The MRQ is 7.633. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.626. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.633TTM7.626+0.008
TTM7.626YOY13.792-6.166
TTM7.6265Y10.312-2.686
5Y10.31210Y10.3120.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.6332.726+4.907
TTM7.6262.732+4.894
YOY13.7923.510+10.282
5Y10.3123.617+6.695
10Y10.3123.499+6.813
1.3.2. Quick Ratio

Measures if Procept Biorobotics Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Procept Biorobotics Corp to the Medical Devices industry mean.
  • A Quick Ratio of 6.65 means the company can pay off $6.65 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Procept Biorobotics Corp:

  • The MRQ is 6.654. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.431. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.654TTM6.431+0.223
TTM6.431YOY12.775-6.344
TTM6.4315Y10.010-3.579
5Y10.01010Y10.0100.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.6541.491+5.163
TTM6.4311.633+4.798
YOY12.7752.113+10.662
5Y10.0102.295+7.715
10Y10.0102.255+7.755

1.4. Solvency of Procept Biorobotics Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Procept Biorobotics Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Procept Biorobotics Corp to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.31 means that Procept Biorobotics Corp assets are financed with 30.6% credit (debt) and the remaining percentage (100% - 30.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Procept Biorobotics Corp:

  • The MRQ is 0.306. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.354. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.306TTM0.354-0.047
TTM0.354YOY0.281+0.072
TTM0.3545Y0.620-0.267
5Y0.62010Y0.6200.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3060.389-0.083
TTM0.3540.386-0.032
YOY0.2810.335-0.054
5Y0.6200.442+0.178
10Y0.6200.461+0.159
1.4.2. Debt to Equity Ratio

Measures if Procept Biorobotics Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Procept Biorobotics Corp to the Medical Devices industry mean.
  • A Debt to Equity ratio of 44.2% means that company has $0.44 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Procept Biorobotics Corp:

  • The MRQ is 0.442. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.560. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.442TTM0.560-0.118
TTM0.560YOY0.402+0.158
TTM0.5605Y0.588-0.029
5Y0.58810Y0.5880.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4420.551-0.109
TTM0.5600.554+0.006
YOY0.4020.479-0.077
5Y0.5880.622-0.034
10Y0.5880.674-0.086

2. Market Valuation of Procept Biorobotics Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Procept Biorobotics Corp generates.

  • Above 15 is considered overpriced but always compare Procept Biorobotics Corp to the Medical Devices industry mean.
  • A PE ratio of -19.41 means the investor is paying $-19.41 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Procept Biorobotics Corp:

  • The EOD is -24.311. Based on the earnings, the company is expensive. -2
  • The MRQ is -19.415. Based on the earnings, the company is expensive. -2
  • The TTM is -16.727. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-24.311MRQ-19.415-4.896
MRQ-19.415TTM-16.727-2.687
TTM-16.727YOY-22.450+5.723
TTM-16.7275Y-13.034-3.693
5Y-13.03410Y-13.0340.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-24.311-1.077-23.234
MRQ-19.415-1.704-17.711
TTM-16.727-2.081-14.646
YOY-22.450-2.978-19.472
5Y-13.034-2.379-10.655
10Y-13.034-1.726-11.308
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Procept Biorobotics Corp:

  • The EOD is -19.955. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -15.936. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -13.743. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-19.955MRQ-15.936-4.019
MRQ-15.936TTM-13.743-2.192
TTM-13.743YOY-23.361+9.618
TTM-13.7435Y-12.823-0.920
5Y-12.82310Y-12.8230.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-19.955-0.932-19.023
MRQ-15.936-1.578-14.358
TTM-13.743-2.973-10.770
YOY-23.361-6.318-17.043
5Y-12.823-5.307-7.516
10Y-12.823-5.171-7.652
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Procept Biorobotics Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 7.61 means the investor is paying $7.61 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Procept Biorobotics Corp:

  • The EOD is 9.527. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.608. Based on the equity, the company is overpriced. -1
  • The TTM is 8.277. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD9.527MRQ7.608+1.919
MRQ7.608TTM8.277-0.670
TTM8.277YOY8.584-0.306
TTM8.2775Y4.942+3.335
5Y4.94210Y4.9420.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD9.5271.876+7.651
MRQ7.6082.372+5.236
TTM8.2772.434+5.843
YOY8.5843.217+5.367
5Y4.9423.893+1.049
10Y4.9424.245+0.697
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Procept Biorobotics Corp.

3.1. Institutions holding Procept Biorobotics Corp

Institutions are holding 91.598% of the shares of Procept Biorobotics Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31FMR Inc14.44510.02377361844-191616-2.5368
2023-12-31Cpmg Inc10.456197.2557532886700
2023-12-31Vanguard Group Inc8.21080.003841845851096942.6919
2023-12-31T. Rowe Price Investment Management,Inc.7.25020.10073695027449281.2309
2023-12-31BlackRock Inc6.58820.0036335763841362914.0499
2023-12-31AllianceBernstein L.P.4.03490.033220563501459365244.4559
2023-12-31Champlain Investment Partners, LLC3.1160.39461588039196451.2526
2023-12-31T. Rowe Price Associates, Inc.2.95430.00851505659-250844-14.2809
2023-12-31Loomis, Sayles & Company LP2.58360.08451316708-28746-2.1365
2023-09-30Citadel Advisors Llc2.18640.00781114287638676134.2854
2023-12-31State Street Corporation2.13010.00221085565538545.2199
2023-12-31Wellington Management Company LLP2.09110.0083106569826094632.4256
2023-12-31Geode Capital Management, LLC1.82770.00419314918928610.6015
2023-12-31Bellevue Group AG1.73720.5676885346-2950-0.3321
2023-12-31BNP Paribas Investment Partners SA1.13120.0673576517174923.129
2023-12-31Massachusetts Financial Services Company1.12150.0077571583-106444-15.6991
2023-12-31American Century Companies Inc1.08480.0159552848-102447-15.6337
2023-12-31Mirae Asset Global Investments (Korea) Co Ltd0.98620.042850260341540.8334
2023-12-31Frank, Rimerman Advisors LLC0.89663.995445695300
2023-09-30Point72 Europe (London) LLP0.79720.81724062714062710
Total 75.6292103.444638543879+2834893+7.4%

3.2. Funds holding Procept Biorobotics Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Fidelity Growth Compy Commingled Pl O3.76380.1182191820900
2023-12-31T. Rowe Price Small-Cap Stock2.96180.66851509441-2200-0.1455
2023-12-31T. Rowe Price US Small-Cap Core Equity2.96180.66851509441-2200-0.1455
2024-02-29Vanguard Total Stock Mkt Idx Inv2.62990.00421340320-4193-0.3119
2024-02-29Fidelity Growth Company Fund2.47650.1023126213400
2024-02-29Fidelity Select Medical Tech and Devcs2.31540.9725118000000
2024-03-31Champlain Small Company Fund, LLC2.31521.26571179945-17910-1.4952
2024-02-29AB Small Cap Growth A2.23211.36841137578-2352-0.2063
2024-02-29Vanguard Small Cap Index2.1710.03811106440102940.9391
2024-03-28iShares Russell 2000 ETF1.94250.074798999359270.6023
2023-12-31T. Rowe Price U.S. SC Core Eq Tr-Z1.44610.66273698322000.2994
2023-12-31T. Rowe Price Instl Small-Cap Stock1.3880.673770738400
2023-12-31T. Rowe Price Health Sciences1.36240.1978694317-212860-23.464
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.28270.031653715-3907-0.5941
2024-03-28Global X Robotics & Artfcl Intllgnc ETF1.27471.121464965000
2023-12-31Champlain Small Company Adv1.26561.1038645000-5000-0.7692
2024-02-29Fidelity Select Health Care1.25580.390864000000
2024-01-31Fidelity Small Cap Growth1.230.50636268749282317.3809
2024-02-29Vanguard Small Cap Growth Index Inv1.21850.086620979103331.6921
2024-03-31Bellevue (Lux) Bellevue Dgtl Hthl I2 EUR1.1027.0205561616-13251-2.3051
Total 38.595817.074419670019-142296-0.7%

3.3. Insider Transactions

Insiders are holding 3.622% of the shares of Procept Biorobotics Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-18Kevin WatersSELL102448.83
2024-03-18Reza ZadnoSELL539148.83
2024-03-18Alaleh NouriSELL44148.83
2024-03-06Alaleh NouriSELL274946.67
2024-03-06Kevin WatersSELL343546.67
2024-03-06Reza ZadnoSELL917946.67
2024-02-12Kevin WatersSELL2234950.16
2024-02-09Alaleh NouriSELL1469449.97
2024-02-09Kevin WatersSELL2867750.09
2024-02-07Alaleh NouriSELL530649.95
2024-02-07Kevin WatersSELL90450
2024-01-09Alaleh NouriSELL1600044.97
2024-01-09Kevin WatersSELL1731045.07
2023-12-14Alaleh NouriSELL320442.95
2023-12-13Kevin WatersSELL7146540.05
2023-12-08Kevin WatersSELL688840.02
2023-12-06Alaleh NouriSELL609639.96
2023-12-06Frederic H MollSELL7900038.75
2023-12-06Kevin WatersSELL436040.02
2023-11-13Morgan Colby WoodSELL2500032.19

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Procept Biorobotics Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.3650.410-189%-0.343-6%0.344-206%0.344-206%
Book Value Per Share--5.5094.460+24%4.463+23%2.204+150%2.204+150%
Current Ratio--7.6337.626+0%13.792-45%10.312-26%10.312-26%
Debt To Asset Ratio--0.3060.354-13%0.281+9%0.620-51%0.620-51%
Debt To Equity Ratio--0.4420.560-21%0.402+10%0.588-25%0.588-25%
Dividend Per Share----0%-0%-0%-0%
Eps---0.540-0.519-4%-0.428-21%-0.372-31%-0.372-31%
Free Cash Flow Per Share---0.657-0.653-1%-0.407-38%-0.396-40%-0.396-40%
Free Cash Flow To Equity Per Share---0.6010.170-454%-0.390-35%0.267-325%0.267-325%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---37.548--------
Intrinsic Value_10Y_min---31.817--------
Intrinsic Value_1Y_max---2.081--------
Intrinsic Value_1Y_min---2.043--------
Intrinsic Value_3Y_max---7.535--------
Intrinsic Value_3Y_min---7.167--------
Intrinsic Value_5Y_max---14.533--------
Intrinsic Value_5Y_min---13.379--------
Market Cap2674601216.000+20%2135909622.0001764253193.500+21%1919821414.000+11%1122199831.375+90%1122199831.375+90%
Net Profit Margin---0.631-0.808+28%-1.249+98%-2.947+367%-2.947+367%
Operating Margin---0.678-0.844+24%-1.079+59%-2.698+298%-2.698+298%
Operating Ratio--1.6781.836-9%2.079-19%3.696-55%3.696-55%
Pb Ratio9.527+20%7.6088.277-8%8.584-11%4.942+54%4.942+54%
Pe Ratio-24.311-25%-19.415-16.727-14%-22.450+16%-13.034-33%-13.034-33%
Price Per Share52.480+20%41.91034.618+21%37.670+11%22.019+90%22.019+90%
Price To Free Cash Flow Ratio-19.955-25%-15.936-13.743-14%-23.361+47%-12.823-20%-12.823-20%
Price To Total Gains Ratio-143.765-25%-114.809-67.048-42%-112.805-2%-79.403-31%-79.403-31%
Quick Ratio--6.6546.431+3%12.775-48%10.010-34%10.010-34%
Return On Assets---0.068-0.079+16%-0.074+9%-0.063-7%-0.063-7%
Return On Equity---0.098-0.126+28%-0.106+8%-0.078-20%-0.078-20%
Total Gains Per Share---0.3650.410-189%-0.343-6%0.344-206%0.344-206%
Usd Book Value--280752000.000227284000.000+24%227443000.000+23%112326125.000+150%112326125.000+150%
Usd Book Value Change Per Share---0.3650.410-189%-0.343-6%0.344-206%0.344-206%
Usd Book Value Per Share--5.5094.460+24%4.463+23%2.204+150%2.204+150%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.540-0.519-4%-0.428-21%-0.372-31%-0.372-31%
Usd Free Cash Flow---33508000.000-33302250.000-1%-20758750.000-38%-20171625.000-40%-20171625.000-40%
Usd Free Cash Flow Per Share---0.657-0.653-1%-0.407-38%-0.396-40%-0.396-40%
Usd Free Cash Flow To Equity Per Share---0.6010.170-454%-0.390-35%0.267-325%0.267-325%
Usd Market Cap2674601216.000+20%2135909622.0001764253193.500+21%1919821414.000+11%1122199831.375+90%1122199831.375+90%
Usd Price Per Share52.480+20%41.91034.618+21%37.670+11%22.019+90%22.019+90%
Usd Profit---27504000.000-26279000.000-4%-23396000.000-15%-19473187.500-29%-19473187.500-29%
Usd Revenue--43581000.00034047750.000+28%18753500.000+132%15837250.000+175%15837250.000+175%
Usd Total Gains Per Share---0.3650.410-189%-0.343-6%0.344-206%0.344-206%
 EOD+5 -3MRQTTM+19 -14YOY+13 -205Y+14 -1910Y+14 -19

4.2. Fundamental Score

Let's check the fundamental score of Procept Biorobotics Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-24.311
Price to Book Ratio (EOD)Between0-19.527
Net Profit Margin (MRQ)Greater than0-0.631
Operating Margin (MRQ)Greater than0-0.678
Quick Ratio (MRQ)Greater than16.654
Current Ratio (MRQ)Greater than17.633
Debt to Asset Ratio (MRQ)Less than10.306
Debt to Equity Ratio (MRQ)Less than10.442
Return on Equity (MRQ)Greater than0.15-0.098
Return on Assets (MRQ)Greater than0.05-0.068
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Procept Biorobotics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.499
Ma 20Greater thanMa 5050.077
Ma 50Greater thanMa 10049.231
Ma 100Greater thanMa 20046.594
OpenGreater thanClose53.650
Total5/5 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets404,717
Total Liabilities123,965
Total Stockholder Equity280,752
 As reported
Total Liabilities 123,965
Total Stockholder Equity+ 280,752
Total Assets = 404,717

Assets

Total Assets404,717
Total Current Assets350,567
Long-term Assets54,150
Total Current Assets
Cash And Cash Equivalents 257,222
Net Receivables 48,376
Inventory 39,756
Other Current Assets 5,213
Total Current Assets  (as reported)350,567
Total Current Assets  (calculated)350,567
+/- 0
Long-term Assets
Property Plant Equipment 48,989
Long-term Assets Other 919
Long-term Assets  (as reported)54,150
Long-term Assets  (calculated)49,908
+/- 4,242

Liabilities & Shareholders' Equity

Total Current Liabilities45,927
Long-term Liabilities78,038
Total Stockholder Equity280,752
Total Current Liabilities
Short-term Debt 1,683
Accounts payable 13,499
Other Current Liabilities 25,089
Total Current Liabilities  (as reported)45,927
Total Current Liabilities  (calculated)40,271
+/- 5,656
Long-term Liabilities
Long term Debt 51,339
Capital Lease Obligations Min Short Term Debt26,182
Long-term Liabilities  (as reported)78,038
Long-term Liabilities  (calculated)77,521
+/- 517
Total Stockholder Equity
Retained Earnings -454,572
Accumulated Other Comprehensive Income 84
Other Stockholders Equity 735,240
Total Stockholder Equity (as reported)280,752
Total Stockholder Equity (calculated)280,752
+/-0
Other
Cash and Short Term Investments 257,222
Common Stock Shares Outstanding 50,589
Current Deferred Revenue5,656
Liabilities and Stockholders Equity 404,717
Net Debt -178,018
Net Invested Capital 332,091
Net Working Capital 304,640
Property Plant and Equipment Gross 52,658
Short Long Term Debt Total 79,204



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
125,971
0
190,577
351,463
337,024
320,912
310,927
324,037
309,329
284,458
272,446
421,125
404,717
404,717421,125272,446284,458309,329324,037310,927320,912337,024351,463190,5770125,971000
   > Total Current Assets 
0
0
110,256
110,256
100,130
176,514
339,470
326,173
307,979
298,337
288,932
272,626
245,580
230,016
368,668
350,567
350,567368,668230,016245,580272,626288,932298,337307,979326,173339,470176,514100,130110,256110,25600
       Cash And Cash Equivalents 
0
0
0
100,130
-100,130
159,224
320,484
304,320
284,288
269,806
249,217
221,859
180,972
149,691
287,087
257,222
257,222287,087149,691180,972221,859249,217269,806284,288304,320320,484159,224-100,130100,130000
       Short-term Investments 
0
0
0
0
200,260
0
0
0
0
0
0
0
0
0
0
0
00000000000200,2600000
       Net Receivables 
0
0
1,549
1,549
5,140
5,140
6,353
4,464
6,992
10,894
12,838
15,272
20,642
33,173
34,622
48,376
48,37634,62233,17320,64215,27212,83810,8946,9924,4646,3535,1405,1401,5491,54900
       Other Current Assets 
0
0
731
731
890
890
2,232
4,242
1,378
3,860
4,519
6,175
4,263
3,739
3,981
5,213
5,2133,9813,7394,2636,1754,5193,8601,3784,2422,23289089073173100
   > Long-term Assets 
0
0
0
15,715
0
14,063
11,993
10,851
12,933
12,590
35,105
36,703
38,878
42,430
52,457
54,150
54,15052,45742,43038,87836,70335,10512,59012,93310,85111,99314,063015,715000
       Property Plant Equipment 
0
0
12,915
12,915
10,498
10,498
9,398
8,324
7,437
6,860
29,544
32,137
34,380
37,920
47,731
48,989
48,98947,73137,92034,38032,13729,5446,8607,4378,3249,39810,49810,49812,91512,91500
       Intangible Assets 
0
0
0
0
0
0
1,818
1,750
1,682
1,614
1,545
1,477
1,409
1,341
1,273
0
01,2731,3411,4091,4771,5451,6141,6821,7501,818000000
       Other Assets 
0
0
777
777
1,679
1,679
777
777
3,814
4,116
4,016
3,089
0
0
0
0
00003,0894,0164,1163,8147777771,6791,67977777700
> Total Liabilities 
0
0
0
308,865
0
396,883
68,151
69,932
68,162
71,739
103,275
112,257
111,332
116,544
121,769
123,965
123,965121,769116,544111,332112,257103,27571,73968,16269,93268,151396,8830308,865000
   > Total Current Liabilities 
0
0
14,526
14,526
13,754
13,754
14,179
16,241
14,757
18,633
27,359
35,290
32,504
35,945
41,356
45,927
45,92741,35635,94532,50435,29027,35918,63314,75716,24114,17913,75413,75414,52614,52600
       Short-term Debt 
0
0
0
6,259
0
1,960
2,032
2,105
2,181
2,258
2,473
2,129
2,998
2,354
1,702
1,683
1,6831,7022,3542,9982,1292,4732,2582,1812,1052,0321,96006,259000
       Short Long Term Debt 
0
0
0
4,551
0
0
0
0
0
0
0
0
0
0
0
0
0000000000004,551000
       Accounts payable 
0
0
1,240
1,240
3,347
3,347
3,590
2,029
2,628
3,342
6,331
9,391
10,341
10,036
13,597
13,499
13,49913,59710,03610,3419,3916,3313,3422,6282,0293,5903,3473,3471,2401,24000
       Other Current Liabilities 
0
0
864
6,794
2,621
7,783
7,709
11,082
7,545
11,170
16,213
20,915
15,222
18,838
21,050
25,089
25,08921,05018,83815,22220,91516,21311,1707,54511,0827,7097,7832,6216,79486400
   > Long-term Liabilities 
0
0
0
294,339
0
383,129
53,972
53,691
53,405
53,106
75,916
76,967
78,828
80,599
80,413
78,038
78,03880,41380,59978,82876,96775,91653,10653,40553,69153,972383,1290294,339000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
51,275
0
0
0051,2750000000000000
       Other Liabilities 
0
0
200
200
200
200
200
200
200
200
200
0
0
0
0
0
0000020020020020020020020020020000
       Deferred Long Term Liability 
0
0
0
0
902
902
1,460
1,496
1,533
1,570
1,609
0
1,805
1,832
0
0
001,8321,80501,6091,5701,5331,4961,4609029020000
> Total Stockholder Equity
0
0
0
-182,894
60,960
-206,306
283,312
267,092
252,750
239,188
220,762
197,072
173,126
155,902
299,356
280,752
280,752299,356155,902173,126197,072220,762239,188252,750267,092283,312-206,30660,960-182,894000
   Common Stock
0
0
0
0
0
0
526,526
0
0
0
0
0
0
0
0
0
000000000526,526000000
   Retained Earnings Total Equity00-402,444-377,1590-320,503-297,890-278,706-261,521-243,173000000
   Accumulated Other Comprehensive Income 
0
0
0
-14
0
-39
-41
-53
-53
32
217
-6
15
-6
-6
84
84-6-615-621732-53-53-41-390-14000
   Capital Surplus 
0
0
0
0
0
0
526,526
528,666
531,509
537,046
541,048
0
550,270
558,352
0
0
00558,352550,2700541,048537,046531,509528,666526,526000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
-14
18,788
-182,894
22,803
-351,463
528,666
531,509
537,046
541,048
545,753
550,270
558,352
726,428
735,240
735,240726,428558,352550,270545,753541,048537,046531,509528,666-351,46322,803-182,89418,788-1400



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue136,191
Cost of Revenue-65,142
Gross Profit71,04971,049
 
Operating Income (+$)
Gross Profit71,049
Operating Expense-180,219
Operating Income-109,170-109,170
 
Operating Expense (+$)
Research Development48,446
Selling General Administrative121,491
Selling And Marketing Expenses0
Operating Expense180,219169,937
 
Net Interest Income (+$)
Interest Income5,568
Interest Expense-3,995
Other Finance Cost-259
Net Interest Income1,832
 
Pretax Income (+$)
Operating Income-109,170
Net Interest Income1,832
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-105,897-112,443
EBIT - interestExpense = -113,165
-105,897
-101,902
Interest Expense3,995
Earnings Before Interest and Taxes (EBIT)-109,170-101,902
Earnings Before Interest and Taxes (EBITDA)-105,363
 
After tax Income (+$)
Income Before Tax-105,897
Tax Provision-0
Net Income From Continuing Ops-106,565-105,897
Net Income-105,897
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses245,361
Total Other Income/Expenses Net3,273-1,832
 

Technical Analysis of Procept Biorobotics Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Procept Biorobotics Corp. The general trend of Procept Biorobotics Corp is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Procept Biorobotics Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Procept Biorobotics Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 54.50.

The bearish price targets are: 50.70 > 50.53 > 50.42.

Tweet this
Procept Biorobotics Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Procept Biorobotics Corp. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Procept Biorobotics Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Procept Biorobotics Corp. The current macd is 1.05879315.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Procept Biorobotics Corp price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Procept Biorobotics Corp. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Procept Biorobotics Corp price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Procept Biorobotics Corp Daily Moving Average Convergence/Divergence (MACD) ChartProcept Biorobotics Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Procept Biorobotics Corp. The current adx is 13.51.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Procept Biorobotics Corp shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Procept Biorobotics Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Procept Biorobotics Corp. The current sar is 48.50.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Procept Biorobotics Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Procept Biorobotics Corp. The current rsi is 57.50. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Procept Biorobotics Corp Daily Relative Strength Index (RSI) ChartProcept Biorobotics Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Procept Biorobotics Corp. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Procept Biorobotics Corp price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Procept Biorobotics Corp Daily Stochastic Oscillator ChartProcept Biorobotics Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Procept Biorobotics Corp. The current cci is 101.83.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Procept Biorobotics Corp Daily Commodity Channel Index (CCI) ChartProcept Biorobotics Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Procept Biorobotics Corp. The current cmo is 16.86.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Procept Biorobotics Corp Daily Chande Momentum Oscillator (CMO) ChartProcept Biorobotics Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Procept Biorobotics Corp. The current willr is -25.35675082.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Procept Biorobotics Corp is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Procept Biorobotics Corp Daily Williams %R ChartProcept Biorobotics Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Procept Biorobotics Corp.

Procept Biorobotics Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Procept Biorobotics Corp. The current atr is 2.55732486.

Procept Biorobotics Corp Daily Average True Range (ATR) ChartProcept Biorobotics Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Procept Biorobotics Corp. The current obv is 2,791,122.

Procept Biorobotics Corp Daily On-Balance Volume (OBV) ChartProcept Biorobotics Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Procept Biorobotics Corp. The current mfi is 70.87.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Procept Biorobotics Corp Daily Money Flow Index (MFI) ChartProcept Biorobotics Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Procept Biorobotics Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Procept Biorobotics Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Procept Biorobotics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.499
Ma 20Greater thanMa 5050.077
Ma 50Greater thanMa 10049.231
Ma 100Greater thanMa 20046.594
OpenGreater thanClose53.650
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Procept Biorobotics Corp with someone you think should read this too:
  • Are you bullish or bearish on Procept Biorobotics Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Procept Biorobotics Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Procept Biorobotics Corp

I send you an email if I find something interesting about Procept Biorobotics Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Procept Biorobotics Corp.

Receive notifications about Procept Biorobotics Corp in your mailbox!